[EN] HIGHLY EFFICIENT NRF2 ACTIVATORS-CO-RELEASING MOLECULE HYBRIDS, THEIR USE IN THE TREATMENT OF INFLAMMATORY OR CARDIOVASCULAR DISEASES AND THEIR PROCESS OF PREPARATION [FR] HYBRIDES MOLÉCULAIRES LIBÉRANT DU CO ET DES ACTIVATEURS DE NRF2 TRÈS EFFICACES, LEUR UTILISATION DANS LE TRAITEMENT DE MALADIES INFLAMMATOIRES OU CARDIOVASCULAIRES ET LEUR PROCÉDÉ DE PRÉPARATION
HIGHLY EFFICIENT NRF2 ACTIVATORS-CO-RELEASING MOLECULE HYBRIDS, THEIR USE IN THE TREATMENT OF INFLAMMATORY OR CARDIOVASCULAR DISEASES AND THEIR PROCESS OF PREPARATION
申请人:Centre National de la Recherche Scientifique
公开号:EP3353186B1
公开(公告)日:2019-08-28
Diverse Nrf2 Activators Coordinated to Cobalt Carbonyls Induce Heme Oxygenase-1 and Release Carbon Monoxide in Vitro and in Vivo
作者:Aniket Nikam、Anthony Ollivier、Michael Rivard、Jayne Louise Wilson、Kevin Mebarki、Thierry Martens、Jean-Luc Dubois-Randé、Roberto Motterlini、Roberta Foresti
DOI:10.1021/acs.jmedchem.5b01509
日期:2016.1.28
The Nrf2/heme oxygenase-1 (HO-1) axis affords significant protection against oxidative stress and cellular damage. We synthesized a series of cobalt-based hybrid molecules (HYCOs) that combine an Nrf2 inducer with a releaser of carbon monoxide (CO), an anti-inflammatory product of HO-1. Two HYCOs markedly increased Nrf2/HO-1 expression, liberated CO and exerted anti-inflammatory activity in vitro.
[EN] HIGHLY EFFICIENT NRF2 ACTIVATORS-CO-RELEASING MOLECULE HYBRIDS, THEIR USE IN THE TREATMENT OF INFLAMMATORY OR CARDIOVASCULAR DISEASES AND THEIR PROCESS OF PREPARATION<br/>[FR] HYBRIDES MOLÉCULAIRES LIBÉRANT DU CO ET DES ACTIVATEURS DE NRF2 TRÈS EFFICACES, LEUR UTILISATION DANS LE TRAITEMENT DE MALADIES INFLAMMATOIRES OU CARDIOVASCULAIRES ET LEUR PROCÉDÉ DE PRÉPARATION